Projects per year
Search results
-
Active
SciClone-Thymalfasin (thymosin alpha 1; Ta1) as an enhancer of vaccine response among older adults receiving booster doses of COVID-19
Mylonakis, E. (PI), Gotur, D. B. (Key Personnel) & Youssef, J. G. (Key Personnel)
10/30/24 → …
Project: Clinical Trial
-
Not started
A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post Single or Double Lung Transplantation (BT-L-CsA-303-FU (BOSTON-3))
Huang, H. J. (PI), Botros, M. (Key Personnel), Goodarzi, A. (Key Personnel), Yau, S. W. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
-
Trifecta-Lung dd-cfDNA-MMDx-DSA Calibration Study
Huang, H. J. (PI), Botros, M. (Key Personnel), Goodarzi, A. (Key Personnel), Yau, S. W. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
-
ECP - BOS - CAG-00324R2
Huang, H. J. (PI), Goodarzi, A. (Key Personnel), Yau, S. W. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
-
Clazakizumab - COVID-19
Huang, H. J. (PI), Gaber, A. O. (Key Personnel), Goodarzi, A. (Key Personnel), Graviss, E. A. (Key Personnel), Moore, L. W. (Key Personnel), Yau, S. W. (Key Personnel) & Youssef, J. G. (Key Personnel)
Project: Clinical Trial
-
Finished
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with Acute Respiratory Distress Syndrome Associated with COVID-19 (Therapeutics for Severely Ill Inpatients
Youssef, J. G. (PI) & Zahiruddin, F. (CoI)
9/15/21 → 3/31/23
Project: Non Profit